Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance

Thomas J. Guzzo, Matthew J. Resnick, Daniel J. Canter, Trinity J. Bivalacqua, Mark A. Rosen, Meredith R. Bergey, Laurie Magerfleisch, John E. Tomazewski, Alan J. Wein, S. Bruce Malkowicz

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance'. Together they form a unique fingerprint.

Medicine & Life Sciences